Tag: license application

DENVER, June 24, 2026 (GLOBE NEWSWIRE) -- Recently, SKHTU Exchange formally submitted its license application materials to the Monetary Authority of Singapore (MAS), marking the entry of the platforms compliance deployment in the Asian market into a substantive review phase. It is understood that the relevant application materials have completed preliminary acceptance, and the subsequent process will proceed to the document review and operational assessment stage in accordance with the regulatory procedures.

DENVER, June 23, 2026 (GLOBE NEWSWIRE) -- Recently, regulatory oversight of digital assets in Europe has continued to intensify. SKHTU Exchange has formally submitted its license application materials to the UK Financial Conduct Authority (FCA) and maintains close communication with the regulatory body during the approval process.

~ 3-year analysis from the Phase I/II study can serve as the primary basis of a Biologics License Application for accelerated approval with FDA ~

DENVER, June 09, 2026 (GLOBE NEWSWIRE) -- Futurionex, a digital asset trading platform, today announced the completion of key enhancements to its client asset protection system. These improvements are part of the company’s preparations for its Markets in Crypto-Assets (MiCA) license application, which remains on track for submission in the third quarter of 2026.

REYKJAVIK, Iceland, June 08, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for AVT16, a proposed interchangeable biosimilar to Entyvio^® (vedolizumab) lyophilized vial for intravenous administration.

- The INDIGO study met its primary and all key secondary endpoints with statistically significant results -